Vifor Pharma: Travere drug for rare kidney condition recommended for EU approval | SaltWire
By Ludwig Burger (Reuters) - Vifor Pharma and partner Travere Therapeutics on Friday won an endorsement for approval from the European Union's drug ...
Read full article »
Vifor Pharma is a Switzerland-based pharmaceutical company that develops nephrology and cardio-renal therapies for the treatment of heart failure and kidney diseases.
Read more